查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604709

辅助生殖技术市场：按类型、诊断、最终用户划分 - 全球预测 2025-2030

Assisted Reproductive Technology Market (ART) by Type (Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer), Diagnosis (Genetic Testing, Hormone Testing, Hysterosalpingography), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年辅助生殖技术市场价值为251.2亿美元，预计到2024年将达到295.2亿美元，复合年增长率为17.57%，到2030年将达到780.4亿美元。

辅助生殖技术 (ART) 包括解决不孕症的医疗程序，例如体外受精 (IVF)、人工授精和冷冻保存。由于生活方式的改变、人口老化以及卵巢症候群等疾病的增加，导致不孕率上升，因此需要辅助生殖技术。辅助生殖技术应用于诊所和医院，帮助个人和夫妇怀孕，主要是为试图克服不孕症的各种挑战的家庭。最终使用领域主要是医疗机构和生育中心。医疗技术的进步、不孕症治疗意识的提高以及不同人群对 ART 治疗接受度的提高推动了 ART 市场的发展。此外，许多地区的政府支持和有利的法规也有助于市场扩张。关键的商机来自于提高手术成功率的人工智慧和机器学习演算法等技术创新，以及不孕症治疗需求不断增加的新兴市场的服务扩展。然而，挑战包括成本高、道德问题、准入有限，以及某些地区缺乏熟练的专业人员。此外，社会和文化偏见也会阻碍采用率。未来的创新可能会集中在提高手术成功率、降低成本以及透过基因图谱进行个人化治疗和改善患者体验。研究和开发的重要领域包括非侵入性诊断工具、改进的胚胎选择方法和荷尔蒙疗法替代方案。对于业务成长而言，将服务扩展到新兴市场并投资远端医疗进行初步咨询可能是有益的。由于技术进步和不孕症盛行率的增加，辅助生殖技术市场充满活力，并具有巨大的成长潜力。然而，克服道德、文化和成本挑战对于持续成功至关重要。

主要市场统计
基准年[2023] 251.2亿美元
预计年份 [2024] 295.2亿美元
预测年份 [2030] 780.4亿美元
复合年增长率（%） 17.57%

市场动态：揭示快速发展的辅助生殖技术市场的关键市场洞察

供需的动态交互作用正在改变辅助生殖技术市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于压力、污染和肥胖导致不孕症患者数量不断增加
    • 新兴国家医疗保健支出增加
    • 卵巢癌、子宫内膜癌和多囊性卵巢症候群的发生率增加
  • 市场限制因素
    • 手术费用高，成功率低。
  • 市场机会
    • 努力提高政府和公共机构的认识
    • 减少治疗併发症的技术进步
  • 市场挑战
    • 新兴经济体缺乏先进的基础设施

波特五力：驾驭辅助生殖科技市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解辅助生殖技术市场的外部影响

外部宏观环境因素在塑造辅助生殖技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解辅助生殖技术市场的竞争状况

对辅助生殖技术市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵辅助生殖技术市场供应商绩效评估

FPNV定位矩阵是评估辅助生殖技术市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划辅助生殖技术市场的成功之路

辅助生殖技术市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于压力、污染和肥胖导致的不孕率增加
      • 新兴国家医疗保健费用上涨
      • 卵巢癌、子宫内膜癌和卵巢症候群（PCOS）的发生率增加
    • 抑制因素
      • 该手术费用昂贵且成功率低。
    • 机会
      • 政府和公共机构为意识提升所做的努力
      • 减少治疗併发症的技术进步
    • 任务
      • 新兴经济体缺乏先进的基础设施
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章辅助生殖科技市场：依类型

  • 人工授精
  • 供体受精
  • 配子输卵管植入
  • 体外受精
  • 诱导排卵
  • 代孕

第七章 诊断辅助生殖技术市场

  • 基因检测
  • 荷尔蒙测试
  • 造影
  • 影像检查
  • 卵巢储备测试
  • 排卵测试

第八章辅助生殖科技市场：依最终使用者分类

  • 诊所
  • 妇科中心
  • 医院
  • 体外受精中心

第九章美洲辅助生殖技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区辅助生殖技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲辅助生殖科技市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Carl Zeiss AG
  • CCB Kitazato, LLC
  • CooperSurgical, Inc. Cooper Companies Inc.
  • Cryolab Ltd.
  • Esco Micro Pte. Ltd.Esco Lifesciences Group
  • Ferring BV
  • FUJIFILM Irvine Scientific, Inc.
  • Genea Limited
  • INVO Bioscience
  • Merck & Co., Inc.
  • Nidacon International AB
  • Planer PLC by Hamilton Thorne, Inc.
  • Rocket Medical plc by Roko AB
  • Thermo Fisher Scientific company
  • Vitrolife AB
Product Code: MRR-436901065A94

The Assisted Reproductive Technology Market was valued at USD 25.12 billion in 2023, expected to reach USD 29.52 billion in 2024, and is projected to grow at a CAGR of 17.57%, to USD 78.04 billion by 2030.

Assisted Reproductive Technology (ART) encompasses medical procedures used to address infertility, including in vitro fertilization (IVF), artificial insemination, and cryopreservation. The necessity of ART stems from rising infertility rates due to lifestyle changes, aging populations, and increased incidences of medical conditions like polycystic ovary syndrome. It is applied in clinics and hospitals to help individuals and couples conceive, catering primarily to families seeking to overcome various fertility challenges. The end-use sectors are primarily healthcare facilities and fertility centers. The market for ART is driven by advancements in medical technologies, growing awareness about fertility treatments, and increasing acceptance of ART procedures across various demographics. Additionally, governmental support and favorable regulations in many regions are contributing to market expansion. Key opportunities arise from technological innovations, such as AI and machine learning algorithms that enhance procedure success rates, and expanding services in emerging markets where fertility treatment demand is rising. However, challenges include high costs, ethical concerns, and limited access in certain regions, alongside a lack of skilled professionals in some areas. Additionally, societal and cultural stigmas can hinder adoption rates. Future innovations could focus on improving technique success rates, reducing costs, and personalizing treatments through genetic mapping and enhanced patient experience. Critical areas ripe for research and development include non-invasive diagnostic tools, improved embryo selection methods, and hormone therapy alternatives. For business growth, expanding services to emerging markets and investing in telehealth for initial consultations could prove beneficial. The ART market is dynamic, with significant growth potential, driven by technological advancements and the increasing prevalence of infertility. However, navigating ethical, cultural, and cost-related challenges will be crucial for sustained success.

KEY MARKET STATISTICS
Base Year [2023] USD 25.12 billion
Estimated Year [2024] USD 29.52 billion
Forecast Year [2030] USD 78.04 billion
CAGR (%) 17.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Assisted Reproductive Technology Market

The Assisted Reproductive Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of infertility cases due to stress, pollution, and obesity
    • Rising healthcare expenditure across emerging nations
    • Increasing prevalence of ovarian & endometrial cancer and PCOS issues
  • Market Restraints
    • High cost required for the procedure and lower success rate
  • Market Opportunities
    • Initiatives from government and public organizations to increase awareness
    • Technological advancements to reduce the treatment complications
  • Market Challenges
    • Dearth of advanced infrastructure in developing economies

Porter's Five Forces: A Strategic Tool for Navigating the Assisted Reproductive Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Assisted Reproductive Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Assisted Reproductive Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Assisted Reproductive Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Assisted Reproductive Technology Market

A detailed market share analysis in the Assisted Reproductive Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Assisted Reproductive Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Assisted Reproductive Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Assisted Reproductive Technology Market

A strategic analysis of the Assisted Reproductive Technology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Assisted Reproductive Technology Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss AG, CCB Kitazato, LLC, CooperSurgical, Inc. Cooper Companies Inc., Cryolab Ltd., Esco Micro Pte. Ltd.Esco Lifesciences Group, Ferring B.V., FUJIFILM Irvine Scientific, Inc., Genea Limited, INVO Bioscience, Merck & Co., Inc., Nidacon International AB, Planer PLC by Hamilton Thorne, Inc., Rocket Medical plc by Roko AB, Thermo Fisher Scientific company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Assisted Reproductive Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer, In Vitro Fertilization, Ovulation Induction, and Surrogacy.
  • Based on Diagnosis, market is studied across Genetic Testing, Hormone Testing, Hysterosalpingography, Imaging Testing, Ovarian Reserve Testing, and Ovulation Testing.
  • Based on End User, market is studied across Clinics, Gynecology Centers, Hospitals, and In Vitro Fertilisation Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of infertility cases due to stress, pollution, and obesity
      • 5.1.1.2. Rising healthcare expenditure across emerging nations
      • 5.1.1.3. Increasing prevalence of ovarian & endometrial cancer and PCOS issues
    • 5.1.2. Restraints
      • 5.1.2.1. High cost required for the procedure and lower success rate
    • 5.1.3. Opportunities
      • 5.1.3.1. Initiatives from government and public organizations to increase awareness
      • 5.1.3.2. Technological advancements to reduce the treatment complications
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of advanced infrastructure in developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Assisted Reproductive Technology Market, by Type

  • 6.1. Introduction
  • 6.2. Artificial Insemination
  • 6.3. Donor Conception
  • 6.4. Gamete Intrafallopian Transfer
  • 6.5. In Vitro Fertilization
  • 6.6. Ovulation Induction
  • 6.7. Surrogacy

7. Assisted Reproductive Technology Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. Genetic Testing
  • 7.3. Hormone Testing
  • 7.4. Hysterosalpingography
  • 7.5. Imaging Testing
  • 7.6. Ovarian Reserve Testing
  • 7.7. Ovulation Testing

8. Assisted Reproductive Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Gynecology Centers
  • 8.4. Hospitals
  • 8.5. In Vitro Fertilisation Centers

9. Americas Assisted Reproductive Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Assisted Reproductive Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Assisted Reproductive Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Carl Zeiss AG
  • 2. CCB Kitazato, LLC
  • 3. CooperSurgical, Inc. Cooper Companies Inc.
  • 4. Cryolab Ltd.
  • 5. Esco Micro Pte. Ltd.Esco Lifesciences Group
  • 6. Ferring B.V.
  • 7. FUJIFILM Irvine Scientific, Inc.
  • 8. Genea Limited
  • 9. INVO Bioscience
  • 10. Merck & Co., Inc.
  • 11. Nidacon International AB
  • 12. Planer PLC by Hamilton Thorne, Inc.
  • 13. Rocket Medical plc by Roko AB
  • 14. Thermo Fisher Scientific company
  • 15. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DONOR CONCEPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HORMONE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IMAGING TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVARIAN RESERVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILISATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023